New Publication Highlights the Ability of the TissueCypher® Barrett's Esophagus Test to Improve and Standardize the Clinical Management of Low-Grade Dysplasia in Patients with Barrett's Esophagus

In the study, management decisions were simulated to determine the most likely care plan with or without use of the TissueCypher test for guidance


Study data shows TissueCypher test results...

Related Keywords

Netherlands ,United States ,Amsterdam ,Noord Holland ,American ,Jacques Bergman ,Castle Biosciences ,Twitter ,Linkedin ,Laboratory Test ,Facebook ,American Gastroenterological Association ,Nasdaq ,Castle Biosciences Inc ,University Of Amsterdam ,Amsterdam University Medical Centers ,Laboratory Developed Test ,Instagram ,Centers For Medicare Medicaid Services ,American Journal ,Gastrointestinal Endoscopy ,Radiofrequency Ablation ,Tissuecypher Barrett ,Esophagus Assay ,Advanced Diagnostic Laboratory Test ,Medicaid Services ,Practice Update ,Mypath Melanoma ,Markets ,